MindBio Announces Private Placement to Raise up to $650,000

(TheNewswire)

Vancouver, British Columbia- TheNewswire - February 18, 2026 – MindBioTherapeutics Corp. (CSE: MBIO); (Frankfurt: WF6);(OTCQB:MBQIF), (the “Company” or“MindBio”), a biotechnology company that is commercialisingprediction technologies for drug and alcohol intoxication detectionusing speech analytics and artificial intelligence, is pleased toannounce it will conduct a non-brokered private placement (the“Offering”) to raise gross proceeds of up to $650,000 to acceleratethe development of its enterprise intoxication detection solution,including the production of proprietary hardware and edge technologiesfor remote deployment in the mining industry.

The Company will offer up to 1,083,333 units (each, an“Unit”) at a price of $0.60 per Unit for gross proceeds of up to$650,000. Each Unit will consist of one common share of the Company(each, a “Share”) and one Share purchase warrant (each, a “Warrant”). EachWarrant will entitle the holder to acquire an additional Share at aprice of $0.80 for a period of thirty-six months following closing ofthe Offering, subject to accelerated expiry in the event the closingprice of the Shares on the Canadian Securities Exchange exceeds $1.00for ten consecutive trading days.

The Company is pursuing opportunities for the use ofits technology in drug and alcohol intoxication detection in themining industry. The Company intends to use the net proceeds from theOffering to accelerate the development and deployment of a proprietaryhardware and edge technology which will enable the remote and scalableuse of MindBio’s intoxication detection solution at mining sites,for recruitment of specialised personnel and for general workingcapital purposes.  

In connection with completion of the Offering, theCompany will pay finders’ fees to eligible third-parties who haveintroduced subscribers to the Offering.  All securities issued inconnection with the Offering will be subject to restrictions on resalefor a period of four-months-and-one-day in accordance with applicablesecurities laws.  

Completion of the Offering remains subject to finalboard and regulatory approvals.

Further, subject to final board approval, the Companyplans to offer certain consultants and employees of the Company up to450,000 stock options, under the Company’s Omnibus Incentive Plan,with each stock option exercisable at a price of $0.75 per option andvalid for a period of 12 months.

For further information, please contact:

Justin Hanka, Chief ExecutiveOfficer

+61 433140886

justin@mindbiotherapeutics.com

www.mindbiotherapeutics.com

About MindBio TherapeuticsCorp.

MindBio is a biotechnologycompany that is commercialising AI prediction technologies for drugand alcohol intoxication detection via voice analysis. The AIprediction model uses over 50 million data points to predict alcoholintoxication with remarkable accuracy, just by using the human voice.The Company is now collecting data that will allow its prediction toolto work on other types of intoxication for use in consumer andenterprise environments.

Cautionary Note ConcerningForward-Looking Statements:

The press release contains “forward-lookingstatements” within the meaning of applicable securities laws,including but not limited to, the Company’s ability to complete theOffering and option grants on the terms announced, and the developmentof its enterprise platform using voice and powered by AI for use indetecting drug and alcohol intoxication. Forward-looking statementscan be identified by words such as: “anticipate,” “intend,”“plan,” “budget,” “believe,” “project,”“estimate,” “expect,” “scheduled,” “forecast,”“strategy,” “future,” “likely,” “may,” “to be,”“could,” “would,” “should,” “will” and similarreferences to future periods or the negative or comparableterminology, as well as terms usually used in the future andconditional. Forward-looking statements are based on assumptions as ofthe date they are provided. However, there canbe no assurance that such assumptions will reflect the actual outcomeof such items or factors.

Additionally, there are known and unknown risk factorsthat could cause the Company’s actual results and financialconditions to differ materially from those indicated in theforward-looking statements. Therefore, you should not rely on any ofthese forward-looking statements. Important risk factors that couldcause actual results and financial conditions to differ materiallyfrom those indicated in the forward-looking statements, include amongothers: the risk that the Company may not be able to raise the grossproceeds of the Offering; the failure to obtain the final regulatoryapproval; and technical challenges in the development or deployment ofits enterprise platform; general economic,market and business conditions in Canada and Australia; marketvolatility; and unforeseen delays in timelines for any of thetransactions or events described in this press release.  Allforward-looking information is qualified in its entirety by thiscautionary statement.

The Company disclaims any obligation to revise orupdate any such forward-looking statement or to publicly announce theresult of any revisions to any of the forward-looking informationcontained herein to reflect future results, events or developments,except as required by law.

Neither the Canadian Securities Exchange nor itsRegulation Service Provider (as that term is defined in the policiesof the Canadian Securities Exchange) accepts responsibility for theadequacy or accuracy of this release.

Copyright (c) 2026 TheNewswire - All rights reserved.